----
Current ValuationThe current P/E ratio is 125.06, within the reasonable range, cheaper than 68.08% of the time in the past 1 years, and the industry ranks 150/223, the industry Median 21.04.
125.06xP/E
¥20.15Stock price
¥0.16Earnings per share
125.06xP/E
Stock price¥20.15Earnings per share¥0.16
Historical Valuation
P/E ratioTypical rangeMedian
- P/E ratio
- 144.29x
- Typical range
- 120.45x–1,747.86x
Peer P/E ratio Comparison
It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 21.04x
0326496128
Industry P/E ratio Comparison
This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 21.04x
0x40x80x120x160x200x
| Name/Symbol | |||
|---|---|---|---|
688166SHBrightGene | 127.27x | -- | ¥13.02B |
688321SHChipscreen | 125.06x | -- | ¥8.93B |
300194SZFuan Pharmaceutical | 121.55x | -- | ¥4.22B |
603520SHStarry | 132.27x | 1,350.00% | ¥3.52B |
600721SHBHC | 138.44x | -- | ¥3.44B |
600613SHShenqi | 122.01x | -- | ¥3.34B |
Risk Warning
Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.
